

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
1255 daily bars · split adjusted
Current price $21.74
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Apr 14, 26 | Exane BNP Paribas |
Daily · Wilder smoothing
| downgrade |
| Outperform |
| Neutral |
| Mar 5, 26 | Erste Group | downgrade | Buy | Hold |
| Jul 18, 25 | Citigroup | downgrade | Buy | Neutral |
| Mar 4, 25 | Exane BNP Paribas | upgrade | Neutral | Outperform |
| Oct 26, 23 | B of A Securities | downgrade | Neutral | Underperform |
| Sep 26, 23 | Morgan Stanley | upgrade | Equal Weight | Overweight |
| Dec 6, 22 | JP Morgan | upgrade | Neutral | Overweight |
| Mar 29, 22 | JP Morgan | downgrade | Overweight | Neutral |
| Jan 28, 22 | B of A Securities | downgrade | Buy | Neutral |
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 25.18 | Oscillator | Buy |
| Stochastic %K (14, 3, 3) | 15.91 | Oscillator | Buy |
| Williams %R (14) | -87.30 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.85 (Hist -0.02) | Oscillator | Strong Sell |
| Average Directional Index (14) | 40.35 (+DI 15.4 / -DI 43.7) | Trend | Strong Sell |
| EMA 20 | 23.12 | MA | Strong Sell |
| SMA 20 | 23.11 | MA | Strong Sell |
| EMA 50 | 24.43 | MA | Strong Sell |
| SMA 50 | 25.01 | MA | Strong Sell |
| SMA 200 | 24.94 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | BCS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 8.0x | 6.8x · sector 20.4x | Discount |
| Forward P/E (FY26E) | 7.9x | EPS est. 2.76 | In line |
| Price / Book | 0.9x | 0.5x | Elevated |
| Price / Sales | 1.8x | 0.9x | Elevated |
| EV / EBITDA | -15.9x | -1.1x | Elevated |
| Return on equity | 10.8% | — | Healthy |
| Gross margin | 96.6% | 63.7% | Above hist. |
| Debt / Equity | 2.95 | 2.60 | Levered |
| Piotroski / Altman Z | 6/9 | Z 0.39 | Distress |
Discounted cash flow model
Stock news · updated daily
New York, New York--(Newsfile Corp. - October 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays PLC may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Barclays PLC securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
The cost of building out the infrastructure needed to satisfy booming demand for artificial intelligence is changing the way major companies allocate resources. That can mean an end to some jobs once done by humans.
Barclays PLC (LSE:BARC), the UK banking group, retains support from UBS and RBC Capital Markets after its third-quarter results fell short of market expectations, with both banks maintaining positive recommendations. UBS reaffirmed its 'buy' rating and trimmed its price target to 588p from 590p, while RBC Capital Markets reiterated 'outperform' and held its target at 525p, against a reference share price of 409p.
NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.
The layoffs just keep coming: Barclays announced it is slashing 5,000 jobs, or about 5% of its workforce. It's attributing the cuts to artificial intelligence, which the bank says has made its operations more efficient.
Barclays PLC ( BCS ) Q3 2026 Earnings Call October 22, 2026 4:30 AM EDT Company Participants Coimbatore Venkatakrishnan - Group CEO & Executive Director Angela Cross - Group Finance Director & Executive Director Conference Call Participants Jonathan Richard Pierce Alvaro de Tejada - Morgan Stanley, Research Division Christopher Cant - Bernstein Autonomous LLP Guy Stebbings - BNP Paribas, Research Division Robert Noble - Deutsche Bank AG, Research Division Pui Mong - BofA Securities, Research Division Chris Hallam - Goldman Sachs Group, Inc., Research Division Jason Napier - UBS Investment Bank, Research Division Andrew Coombs - Citigroup Inc., Research Division Amit Goel - Mediobanca - Banca di credito finanziario S.p.A., Research Division Edward Firth - Keefe, Bruyette & Woods Limited, Research Division Benjamin Toms - RBC Capital Markets, Research Division Alberto Artoni - Intesa Sanpaolo Equity Research Nicolas Payen - Kepler Cheuvreux, Research Division Presentation Operator Welcome to Barclays Q3 2026 Results Analyst and Investor Conference Call.
Barclays delivered mixed Q3 2026 results, with resilient operating performance but revenue and earnings below market expectations due to investment banking softness. BCS is executing a significant cost-cutting program, targeting a cost-to-income ratio in the low 50s% by 2028, supported by technology and workforce reductions. Asset quality remains robust, with a group cost of risk at 43bps, below guidance, and capital strength enabling a new £500 million share buyback.
Barclays plans to eliminate about 5,000 jobs this year as the British bank expands its use of artificial intelligence (AI) and technology to improve productivity and reduce costs, even as third-quarter profits rose. The reductions represent about 5% of the bank's workforce, Barclays said Thursday (Oct. 22).
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Oct 22, 2026 | 0.67 | 0.66 | Miss -1.5% | $9.84B |
| Jul 28, 2026 | 0.89 | 0.90 | Beat 1.1% | $11.08B |
| Apr 28, 2026 | 0.75 | 0.76 | Beat 1.3% | $11.02B |
| Feb 10, 2026 | 0.42 | 0.46 | Beat 9.5% | $9.68B |
| Oct 22, 2025 | 0.54 | 0.56 | Beat 3.7% | $9.64B |
| Jul 29, 2025 | 0.50 | 0.62 | Beat 24.0% | $25.11B |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 6-K | Oct 23, 2026 | 2026-10-23 07:03:10 | View |
| 6-K | Oct 22, 2026 | 2026-10-22 12:45:31 | View |
| 6-K | Oct 22, 2026 | 2026-10-22 06:14:06 | View |
| 6-K | Oct 9, 2026 | 2026-10-09 06:30:06 | View |
| 6-K | Oct 1, 2026 | 2026-10-01 06:01:10 | View |
| 6-K | Sep 24, 2026 | 2026-09-24 15:23:42 | View |
| 6-K | Sep 24, 2026 | 2026-09-24 12:12:23 | View |
| 6-K | Sep 18, 2026 | 2026-09-18 12:45:33 | View |
| 25-NSE | Sep 14, 2026 | 2026-09-14 13:29:34 | View |
| 6-K | Sep 11, 2026 | 2026-09-11 12:01:11 | View |
Proxy statement (DEF 14A) disclosures
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings